Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.

Lynch ME, Campbell F.

Br J Clin Pharmacol. 2011 Nov;72(5):735-44. doi: 10.1111/j.1365-2125.2011.03970.x. Review.

2.

The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.

Boychuk DG, Goddard G, Mauro G, Orellana MF.

J Oral Facial Pain Headache. 2015 Winter;29(1):7-14. doi: 10.11607/ofph.1274. Review.

PMID:
25635955
3.

[Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].

Petzke F, Enax-Krumova EK, Häuser W.

Schmerz. 2016 Feb;30(1):62-88. doi: 10.1007/s00482-015-0089-y. Review. German. Erratum in: Schmerz. 2017 Sep 6;:.

PMID:
26830780
4.

Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials.

Lynch ME, Ware MA.

J Neuroimmune Pharmacol. 2015 Jun;10(2):293-301. doi: 10.1007/s11481-015-9600-6. Epub 2015 Mar 22. Review.

PMID:
25796592
6.

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review.

Campbell FA, Tramèr MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ.

BMJ. 2001 Jul 7;323(7303):13-6. Review.

7.

Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis.

Meng H, Johnston B, Englesakis M, Moulin DE, Bhatia A.

Anesth Analg. 2017 Nov;125(5):1638-1652. doi: 10.1213/ANE.0000000000002110. Review.

PMID:
28537982
8.

Neuromodulators for pain management in rheumatoid arthritis.

Richards BL, Whittle SL, Buchbinder R.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008921. doi: 10.1002/14651858.CD008921.pub2. Review.

PMID:
22258992
9.

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.

Iskedjian M, Bereza B, Gordon A, Piwko C, Einarson TR.

Curr Med Res Opin. 2007 Jan;23(1):17-24.

PMID:
17257464
10.

Methadone for chronic non-cancer pain in adults.

Haroutiunian S, McNicol ED, Lipman AG.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008025. doi: 10.1002/14651858.CD008025.pub2. Review.

PMID:
23152251
11.
12.

[Use of cannabinoids in palliative medicine].

Ernst G, Kongsgaard UE.

Tidsskr Nor Laegeforen. 2008 Apr 3;128(7):822-5. Review. Norwegian.

13.

Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials.

Deshpande A, Mailis-Gagnon A, Zoheiry N, Lakha SF.

Can Fam Physician. 2015 Aug;61(8):e372-81. Review.

14.

Cannabinoids for pain management.

Thaler A, Gupta A, Cohen SP.

Adv Psychosom Med. 2011;30:125-38. doi: 10.1159/000324070. Epub 2011 Apr 19. Review.

PMID:
21508629
15.

Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.

Burns TL, Ineck JR.

Ann Pharmacother. 2006 Feb;40(2):251-60. Epub 2006 Jan 31. Review.

PMID:
16449552
16.

Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.

Smith PF.

Curr Opin Investig Drugs. 2002 Jun;3(6):859-64. Review.

PMID:
12137404
17.

Antidepressants for neuropathic pain.

Saarto T, Wiffen PJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005454. Review.

PMID:
17943857
18.

Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults.

Gill D, Derry S, Wiffen PJ, Moore RA.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD009183. doi: 10.1002/14651858.CD009183.pub2. Review.

PMID:
21975791
19.

Cannabis and its derivatives: review of medical use.

Leung L.

J Am Board Fam Med. 2011 Jul-Aug;24(4):452-62. doi: 10.3122/jabfm.2011.04.100280. Review.

20.

Dronabinol and chronic pain: importance of mechanistic considerations.

de Vries M, van Rijckevorsel DC, Wilder-Smith OH, van Goor H.

Expert Opin Pharmacother. 2014 Aug;15(11):1525-34. doi: 10.1517/14656566.2014.918102. Epub 2014 May 12. Review.

PMID:
24819592

Supplemental Content

Support Center